Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development

Profibrotic Signaling and HCC Risk during Chronic Viral Hepatitis: Biomarker Development

Despite breakthroughs in antiviral therapies, chronic viral hepatitis B and C are still the major causes of liver fibrosis and hepatocellular carcinoma (HCC). Importantly, even in patients with controlled infection or viral cure, the cancer risk cannot be fully eliminated, highlighting a persisting...

Full description

Bibliographic Details
Main Authors: Alessia Virzì, Victor Gonzalez-Motos, Simona Tripon, Thomas F. Baumert, Joachim Lupberger
Format: Article
Language:English
Published: MDPI AG 2021-03-01
Series:Journal of Clinical Medicine
Subjects:
HBV
HCV
biomarkers
liver disease
HCC
cure
Online Access:https://www.mdpi.com/2077-0383/10/5/977

Similar Items

Similar Items